SSA
AFIB

Schonfeld Strategic Advisors’s Acutus Medical Inc AFIB Stock Holding History

Schonfeld Strategic Advisors’s Portfolio AFIB Stock Details AFIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-171,100
Closed -$119K – 2328
2023
Q3 		$119K Buy
171,100
+2,900
+2% +$1.88K ﹤0.01% 1476
2023
Q2 		$149K Sell
168,200
-1,900
-1% -$1.61K ﹤0.01% 1642
2023
Q1 		$128K Buy
170,100
+155,500
+1,065% +$203K ﹤0.01% 1643
2022
Q4 		$16.8K Buy
+14,600
New +$12.1K ﹤0.01% 2335
2022
Q2 		– Sell
-37,401
Closed -$52K – 3149
2022
Q1 		$52K Buy
+37,401
New +$80K ﹤0.01% 2337
2021
Q3 		– Sell
-140,131
Closed -$2.38M – 2556
2021
Q2 		$2.38M Sell
140,131
-9,829
-7% -$144K 0.03% 659
2021
Q1 		$2M Buy
149,960
+14,360
+11% +$323K 0.02% 659
2020
Q4 		$3.91M Buy
135,600
+71,400
+111% +$1.93M 0.05% 456
2020
Q3 		$1.91M Buy
+64,200
New +$1.95M 0.04% 523

Other funds holding AFIB

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Schonfeld Strategic Advisors's AFIB Position: Q4 2023 in Review

Schonfeld Strategic Advisors sold out of Acutus Medical Inc (AFIB) in Q4 2023, closing a stake of 171,100 shares — an estimated $119K sold.

Schonfeld Strategic Advisors first reported a position in AFIB in Q3 2020 and held it in 9 quarters. The position peaked at $3.91M in Q4 2020. 29 funds tracked by Wall St. Rank hold AFIB as of Q4 2023.

  • Schonfeld Strategic Advisors reported no remaining Acutus Medical Inc position as of Q4 2023 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 171,100 Acutus Medical Inc shares in Q4 2023, an estimated $119K.
  • Schonfeld Strategic Advisors first reported a position in Acutus Medical Inc in Q3 2020 and held it in 9 quarters.
  • Schonfeld Strategic Advisors's Acutus Medical Inc position peaked at $3.91M in Q4 2020.
  • 29 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q4 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.